Neoplasia — MCQs

Neoplasia Indian Medical PG Practice Questions and MCQs

Question 251: All of the following are considered hallmarks of cancer except?

A. Limitless replicative potential
B. Insensitivity to growth-inhibitory signals
C. Self-sufficiency in growth signals
D. None of the above (Correct Answer)

Explanation: **Explanation:** The concept of the **"Hallmarks of Cancer,"** originally proposed by Hanahan and Weinberg, defines the fundamental biological capabilities acquired by cells during the multistep development of human tumors [1]. 1. **Why "None of the above" is correct:** All three options (A, B, and C) are part of the original six hallmarks of cancer [1]. Since all listed options are indeed hallmarks, none of them can be excluded, making "None of the above" the correct choice. 2. **Analysis of Options:** * **Self-sufficiency in growth signals (Option C):** Normal cells require external growth factors to proliferate. Cancer cells acquire the ability to synthesize their own ligands (autocrine stimulation) or overexpress receptors (e.g., HER2/neu), allowing them to grow independently [1], [4]. * **Insensitivity to growth-inhibitory signals (Option B):** Cancer cells evade "stop" signals. This is primarily achieved through the inactivation of tumor suppressor genes like **RB** (Retinoblastoma) and **TP53** [1]. * **Limitless replicative potential (Option A):** Normal cells have a finite lifespan (Hayflick limit) due to telomere shortening. Cancer cells maintain their telomeres, usually by upregulating the enzyme **telomerase**, rendering them "immortal" [2]. **High-Yield Clinical Pearls for NEET-PG:** * **The Original 6 Hallmarks:** 1. Self-sufficiency in growth signals, 2. Insensitivity to anti-growth signals, 3. Evading apoptosis, 4. Limitless replicative potential, 5. Sustained angiogenesis, 6. Tissue invasion and metastasis [1], [3]. * **Emerging Hallmarks (Added in 2011):** Deregulating cellular energetics (e.g., **Warburg effect**) and Avoiding immune destruction [1]. * **Enabling Characteristics:** Genomic instability and Tumor-promoting inflammation [3]. * **Most common tumor suppressor gene mutated in human cancer:** **TP53** (Guardian of the Genome). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 290-291. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 311-312. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 288-290. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 292.

Question 252: What is the term for excessive fibrosis in a tumor?

A. Anaplasia
B. Metaplasia
C. Desmoplasia (Correct Answer)
D. Dysplasia

Explanation: **Explanation:** **Correct Answer: C. Desmoplasia** Desmoplasia refers to the proliferation of non-neoplastic connective tissue (fibrous stroma) induced by certain tumors, particularly carcinomas [1]. This excessive fibrosis occurs as a host response to the invading tumor cells [1]. Clinically, desmoplasia results in the characteristic "stony hard" or "scirrhous" consistency of certain tumors, such as infiltrating ductal carcinoma of the breast or linitis plastica in gastric cancer [1]. **Analysis of Incorrect Options:** * **A. Anaplasia:** This refers to a lack of differentiation in cells. It is a hallmark of malignancy where cells lose their structural and functional resemblance to normal tissue [1]. * **B. Metaplasia:** This is a reversible change in which one adult cell type (epithelial or mesenchymal) is replaced by another adult cell type, usually as an adaptation to chronic irritation (e.g., Squamous metaplasia in the bronchus of smokers). * **C. Dysplasia:** This refers to disordered growth and maturation of an epithelium, characterized by a loss of architectural uniformity and cellular pleomorphism. It is often a precursor to malignancy (Carcinoma in situ). **NEET-PG High-Yield Pearls:** * **Scirrhous Tumor:** A tumor with prominent desmoplasia (e.g., Breast cancer, Pancreatic adenocarcinoma) [1]. * **Mechanism:** Tumor cells secrete growth factors like **TGF-β** (Transforming Growth Factor-beta), which stimulate fibroblasts to produce collagen [1]. * **Distinction:** Unlike the tumor cells themselves, the fibrous stroma in desmoplasia is **polyclonal** and non-neoplastic [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 203-206.

Question 253: Which of the following markers is NOT characteristically positive in Wilms tumor?

A. Desmin
B. Vimentin
C. TTF-1 (Correct Answer)
D. Cytokeratin

Explanation: Wilms tumor (Nephroblastoma) is a **triphasic tumor** consisting of three components: blastema, stroma, and epithelium [1], [2]. Because it originates from the primitive metanephric blastema, it expresses a diverse array of markers reflecting these different lineages. * **Why TTF-1 is the correct answer:** **TTF-1 (Thyroid Transcription Factor-1)** is a highly specific marker for tumors of **thyroid** and **lung** (adenocarcinoma) origin. It is not expressed in renal embryonal tissues or Wilms tumor. Therefore, it is the "odd one out." * **Why the other options are incorrect:** * **Vimentin:** This is a marker for mesenchymal cells. It is characteristically positive in the **stromal** and **blastemal** components of Wilms tumor. * **Cytokeratin:** This is a marker for epithelial differentiation. It is positive in the **tubular/epithelial** elements of the tumor. * **Desmin:** Wilms tumor stroma often undergoes heterologous differentiation. The presence of skeletal muscle differentiation (rhabdomyoblastic) is common, making **Desmin** (and Myogenin) frequently positive in the stromal component. **NEET-PG High-Yield Pearls:** 1. **WT1 Gene:** Located on chromosome **11p13**. It is the most important diagnostic marker for Wilms tumor (nuclear staining) [1]. 2. **Triphasic Pattern:** Blastema (small blue cells), Stroma (fibroblastic/myoid), and Epithelium (abortive tubules/glomeruli) [2]. 3. **WAGR Syndrome:** Wilms tumor, Aniridia, Genitourinary anomalies, and mental Retardation (associated with WT1 deletion) [1]. 4. **Beckwith-Wiedemann Syndrome:** Associated with **WT2** (11p15.5) and organomegaly/hemihypertrophy. 5. **Prognosis:** The presence of **anaplasia** (p53 mutation) is the most important histological predictor of poor outcome. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 487-488. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 488-490.

Question 254: Which of the following is the best marker to distinguish Thymoma from lymphoma?

A. CD19
B. Cytokeratin (Correct Answer)
C. CD79a
D. Laminin

Explanation: ### Explanation The key to distinguishing between a thymoma and a lymphoma lies in identifying the **cell of origin** [3]. **1. Why Cytokeratin is the Correct Answer:** Thymoma is a neoplasm arising from the **thymic epithelial cells** [1]. Cytokeratin is an intermediate filament found specifically in epithelial tissues [4]. Therefore, immunohistochemical (IHC) staining for **Cytokeratin** will be positive in thymoma, highlighting the neoplastic epithelial network. While thymomas often contain a dense population of reactive T-lymphocytes (thymocytes), the underlying malignancy is epithelial [1]. **2. Analysis of Incorrect Options:** * **CD19 and CD79a:** These are classic **B-cell markers**. While they are excellent for identifying B-cell lymphomas (like Diffuse Large B-cell Lymphoma), they will be negative in the epithelial cells of a thymoma. Furthermore, the lymphocytes found within a thymoma are typically T-cells, not B-cells [2]. * **Laminin:** This is a major glycoprotein of the basal lamina. While it plays a role in cell adhesion and basement membrane structure, it is not a specific diagnostic marker used to differentiate between epithelial and lymphoid malignancies in clinical practice. **3. NEET-PG High-Yield Pearls:** * **Thymoma Associations:** Most commonly associated with **Myasthenia Gravis** (30-45% of patients) and Pure Red Cell Aplasia [2]. * **IHC Profile:** Thymoma = Cytokeratin (+). Lymphoma = CD45/LCA (+) (Leukocyte Common Antigen). * **Hassall’s Corpuscles:** These are diagnostic histological features of the thymus; their presence within a tumor mass strongly suggests a thymic origin [2]. * **Mediastinal Masses:** Remember the "4 Ts" of anterior mediastinal masses: Thymoma, Teratoma, Thyroid (retrosternal goiter), and "Terrible" Lymphoma [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 634-635. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 634. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 571-572. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 208-209.

Question 255: Knudson's two-hit hypothesis is characteristically associated with which condition?

A. Neuroblastoma
B. Melanoma
C. Retinoblastoma (Correct Answer)
D. Renal Cell Carcinoma (RCC)

Explanation: **Explanation:** **Knudson’s Two-Hit Hypothesis** is the fundamental concept explaining how tumor suppressor genes (TSGs) contribute to carcinogenesis [1]. It states that both alleles of a TSG must be inactivated (two "hits") for a tumor to develop. **Why Retinoblastoma is the Correct Answer:** Alfred Knudson formulated this hypothesis specifically while studying **Retinoblastoma (RB)** [2]. * **Familial cases:** The first "hit" is inherited (germline mutation), and the second "hit" occurs somatically in the retinal cell [1]. This leads to early-onset, often bilateral tumors. * **Sporadic cases:** Both "hits" occur somatically in the same retinal cell [2]. This requires more time, leading to late-onset, unilateral tumors. The **RB1 gene** (Chromosome 13q14) is the prototype TSG involved [1]. **Analysis of Incorrect Options:** * **Neuroblastoma:** Associated with **N-MYC amplification** (an oncogene, not a TSG following the two-hit model) and 1p deletions. * **Melanoma:** Most commonly associated with **BRAF mutations** (V600E) or CDKN2A mutations, but it is not the classic model for the two-hit hypothesis [4]. * **Renal Cell Carcinoma (RCC):** While the VHL gene in Clear Cell RCC follows a two-hit pattern, the hypothesis was historically and characteristically described for Retinoblastoma. **NEET-PG High-Yield Pearls:** * **RB Protein Function:** It regulates the **G1-S checkpoint** by binding to the E2F transcription factor [3]. When phosphorylated (inactivated) by Cyclin D-CDK4/6, it releases E2F, allowing cell cycle progression [3]. * **"Governor of the Cell Cycle":** RB is often referred to by this title. * **Secondary Malignancy:** Patients with hereditary Retinoblastoma have a high risk of developing **Osteosarcoma** later in life. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 298-300. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 300-301. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298.

Question 256: What is Ackerman's tumor also known as?

A. Mucoepidermoid carcinoma
B. Epidermoid carcinoma
C. Squamous cell carcinoma (Correct Answer)
D. Adenocarcinoma

Explanation: **Explanation:** **Ackerman’s tumor**, also known as **Verrucous Carcinoma**, is a distinct, well-differentiated variant of **Squamous Cell Carcinoma (SCC)**. It is characterized by a slow-growing, exophytic, "wart-like" appearance and is most commonly found in the oral cavity (associated with tobacco chewing/snuff) and the genitourinary tract. **Why the correct answer is right:** While Verrucous Carcinoma is the specific name, it is pathologically classified under the umbrella of **Squamous Cell Carcinoma**. It is unique because, despite its locally aggressive nature and large size, it rarely metastasizes [2]. Histologically, it shows "pushing margins" rather than the infiltrative growth seen in conventional SCC. **Why other options are incorrect:** * **A. Mucoepidermoid carcinoma:** This is the most common malignant tumor of the salivary glands [1], containing a mix of mucus-producing, intermediate, and squamous cells. It is not synonymous with Ackerman’s tumor. * **B. Epidermoid carcinoma:** This is simply another term for Squamous Cell Carcinoma. While technically correct in a broad sense, "Squamous Cell Carcinoma" is the standard terminology used in pathology exams to classify Ackerman’s tumor. * **D. Adenocarcinoma:** This refers to a malignancy of glandular epithelium. Ackerman’s tumor arises from the surface squamous epithelium, not glands. **Clinical Pearls for NEET-PG:** * **Classic Site:** Buccal mucosa (often called "Snuff dipper’s cancer"). * **Morphology:** "Cauliflower-like" or verrucous growth. * **Histology:** Minimal cytological atypia and a characteristic "pushing" border (not infiltrative). * **Prognosis:** Excellent, as it is locally invasive but has very low metastatic potential. * **Important Distinction:** Do not confuse with **Buschke-Löwenstein tumor**, which is a giant condyloma acuminatum (verrucous carcinoma of the anogenital region). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 751-753. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Disorders Involving Inflammatory And Haemopoietic Cells, pp. 644-645.

Question 257: Ebstein Barr virus has been implicated in the following malignancies except?

A. Hodgkin's disease
B. B-cell lymphoma
C. Nasopharyngeal carcinoma
D. Multiple myeloma (Correct Answer)

Explanation: **Explanation:** The correct answer is **Multiple Myeloma**. Epstein-Barr Virus (EBV) is a potent oncogenic herpesvirus that primarily infects B-lymphocytes and epithelial cells [2]. While EBV is strongly associated with several lymphoid and epithelial malignancies, it has **no established causal role in the pathogenesis of Multiple Myeloma**, which is a plasma cell dyscrasia primarily driven by chromosomal translocations (e.g., involving the IgH locus) and mutations in the MYC or RAS pathways. **Analysis of Options:** * **Hodgkin’s Disease (A):** EBV is found in approximately 40-50% of cases, particularly the **Mixed Cellularity subtype**. The virus resides in the characteristic Reed-Sternberg cells. * **B-cell Lymphoma (B):** EBV is a major driver of several B-cell malignancies, most notably **Burkitt Lymphoma** (endemic form), Diffuse Large B-cell Lymphoma (DLBCL), and lymphomas in immunocompromised patients (e.g., post-transplant lymphoproliferative disorder) [1, 4]. * **Nasopharyngeal Carcinoma (C):** There is a 100% association between EBV and the **undifferentiated type** (Type III) of Nasopharyngeal Carcinoma [4]. The viral genome is found in all tumor cells [2]. **High-Yield Clinical Pearls for NEET-PG:** * **EBV Receptor:** It enters B-cells via the **CD21** (CR2) receptor. * **Major Oncoprotein:** **LMP-1** (Latent Membrane Protein 1) is the most important viral protein; it mimics CD40 signaling to drive B-cell proliferation [3]. * **Other EBV Associations:** Gastric adenocarcinoma (subset), NK/T-cell lymphoma, and Oral Hairy Leukoplakia (in HIV). * **Diagnostic Marker:** Atypical lymphocytes (Downey cells) in Infectious Mononucleosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 261-262. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 219-220. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 335-336. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 744-745.

Question 258: Conventional cytogenetics are difficult in solid tumors, especially in case of carcinoma cervix. What is the reason?

A. High mitotic rate
B. Bacterial contamination of the specimen
C. Good metaphase activity (Correct Answer)
D. Inadequate biopsy specimen

Explanation: **Explanation:** Conventional cytogenetics (karyotyping) requires cells to be in the **metaphase** stage of mitosis, as this is when chromosomes are most condensed and visible. In the context of solid tumors like carcinoma cervix, obtaining high-quality chromosomal spreads is notoriously difficult. **Why "Good metaphase activity" is the correct answer:** The term "Good metaphase activity" in this context is a bit of a misnomer in clinical practice; it refers to the **difficulty in obtaining quality metaphase spreads** from solid tumor cultures. Unlike hematological malignancies (where cells are easily suspended), solid tumors have a low growth fraction *in vitro*, poor quality of chromosome morphology, and a tendency for the cells to undergo necrosis or fail to divide in culture. Therefore, the lack of sufficient, high-quality metaphase cells makes conventional cytogenetics technically challenging [1]. **Analysis of Incorrect Options:** * **A. High mitotic rate:** A high mitotic rate would theoretically make cytogenetics easier, as more cells would be entering division. * **B. Bacterial contamination:** While a risk in cervical samples (due to the vaginal flora), it is a technical complication that can be managed with antibiotics in culture media and is not the primary biological reason for cytogenetic failure. * **D. Inadequate biopsy specimen:** While a common practical issue, it is not the specific biological hurdle that distinguishes solid tumor cytogenetics from other types of genetic testing. **High-Yield Pearls for NEET-PG:** * **Solid Tumors vs. Leukemia:** Cytogenetics is the gold standard for leukemias (e.g., t(9;22) in CML), but **FISH (Fluorescence In Situ Hybridization)** or **CGH (Comparative Genomic Hybridization)** are preferred for solid tumors because they do not require actively dividing cells [1]. * **Cervical Cancer:** The primary driver is high-risk HPV (16, 18), which integrates into the host genome, causing instability that is often too complex for simple karyotyping. * **Metaphase Arrest:** Colchicine is the agent used in the lab to arrest cells in metaphase by inhibiting spindle formation. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 225-226.

Question 259: Tumour antigen S-100 is present in which of the following?

A. Choriocarcinoma
B. Breast cancer
C. Neural tumours (Correct Answer)
D. Testicular tumours

Explanation: **Explanation:** **S-100** is a calcium-binding protein primarily found in cells derived from the **neural crest**. It is a highly sensitive, though not highly specific, immunohistochemical (IHC) marker used to identify tumors of neuroectodermal origin. **Why Neural Tumours are Correct:** S-100 is the hallmark marker for cells of the peripheral nervous system (Schwann cells) and melanocytes. It is consistently positive in: * **Neural Tumours:** Schwannoma, Neurofibroma, and Granular cell tumors [1]. * **Melanocytic Tumours:** Malignant Melanoma (S-100 is the most sensitive marker here). * **Cartilaginous Tumours:** Chondrosarcoma. * **Langerhans Cell Histiocytosis (LCH).** **Why Other Options are Incorrect:** * **Choriocarcinoma:** This is a germ cell tumor (trophoblastic) [2]. Its characteristic marker is **beta-hCG**. * **Breast Cancer:** Common markers include **ER/PR, HER2/neu**, and **E-cadherin**. While some rare subtypes (like metaplastic carcinoma) might show focal S-100, it is not a diagnostic marker for breast cancer. * **Testicular Tumours:** These are primarily germ cell tumors. Markers include **AFP** (Yolk sac tumor), **hCG** (Choriocarcinoma), and **PLAP** (Seminoma). **High-Yield Clinical Pearls for NEET-PG:** * **Most sensitive marker for Melanoma:** S-100 (but HMB-45 and Melan-A are more specific). * **S-100 in Salivary Glands:** It marks **myoepithelial cells** (useful in diagnosing Pleomorphic Adenoma). * **Differentiating Neurofibroma vs. Dermatofibroma:** Neurofibroma is S-100 positive; Dermatofibroma is Factor XIIIa positive. * **Langerhans Cells:** S-100 and **CD1a** (along with Birbeck granules on EM) are diagnostic. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1249-1251. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1317-1318.

Question 260: HCG is a tumor marker for which of the following conditions?

A. Choriocarcinoma (Correct Answer)
B. Colon carcinoma
C. Serous cystadenoma
D. Teratoma

Explanation: **Explanation:** **Human Chorionic Gonadotropin (hCG)** is a glycoprotein hormone normally produced by syncytiotrophoblastic cells of the placenta. In the context of neoplasia, it serves as a highly sensitive and specific tumor marker for tumors derived from these cells. 1. **Why Choriocarcinoma is correct:** Choriocarcinoma is a malignant proliferation of trophoblastic tissue (cytotrophoblasts and syncytiotrophoblasts) [1]. Since syncytiotrophoblasts are the physiological source of hCG, these tumors secrete massive amounts of the hormone into the blood [1]. It is used for diagnosis, monitoring treatment response, and detecting recurrence [1], [3]. 2. **Why other options are incorrect:** * **Colon carcinoma:** The primary tumor marker is **CEA** (Carcinoembryonic Antigen). * **Serous cystadenoma:** This is a benign ovarian tumor. While its malignant counterpart (Serous cystadenocarcinoma) uses **CA-125** as a marker, benign cystadenomas typically do not have specific serum markers. * **Teratoma:** Mature teratomas generally do not secrete markers [1]. However, if a teratoma contains yolk sac elements, **AFP** (Alpha-fetoprotein) may be raised; if it contains choriocarcinoma elements, hCG may rise, but it is not the primary marker for a pure teratoma [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Germ Cell Tumors:** hCG is elevated in 100% of Choriocarcinomas and approximately 10-15% of Seminomas (due to scattered syncytiotrophoblastic giant cells) [4]. * **Combined Markers:** In Non-Seminomatous Germ Cell Tumors (NSGCTs), both **hCG and AFP** are often elevated together [2]. * **Biological Mimicry:** High levels of hCG can cross-react with TSH receptors, potentially leading to **hyperthyroidism** in patients with gestational trophoblastic disease [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1035-1036. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 512-513. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1044-1046. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 980-982.

Practice by Chapter

Nomenclature and Classification of Tumors

Practice Questions

Characteristics of Benign and Malignant Neoplasms

Practice Questions

Molecular Basis of Cancer

Practice Questions

Carcinogenesis and Carcinogens

Practice Questions

Tumor Progression and Metastasis

Practice Questions

Tumor Markers

Practice Questions

Paraneoplastic Syndromes

Practice Questions

Genetic Basis of Cancer

Practice Questions

Tumor Immunity

Practice Questions

Cancer Epidemiology and Prevention

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Neoplasia — MCQs

Neoplasia — MCQs

On this page

Practice by Chapter

Want unlimited practice?